Cited 0 time in
Efficacy and safety of CT-P13(infliximab biosimilar) over two years in patients with rheumatoid arthritis: comparison between continued CT-P`13 and switching from infliximab to CT-P13
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
